Form D · Pharmaceuticals
Kirax Corp
Bonita Springs, FL · CIK 1329666
Offering snapshot reported Sep 12, 2012 · SEC filing
- Reported sold
- $541K Offering amount: $1.97M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2012 | Initial | $540,760 | No comparison | 8 | SEC filing |
| Apr 16, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184021
Source: Form D, filed Sep 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarita Chauhan, Ph.D. | Executive |
| Maninder Chopra, Ph.D. | Executive |
| Neil W. Flanzraich | Director, Executive |
| Pedro Granadillo | Director |
| Peter M. Kash, Ed.D. | Director |
| Joshua A. Kazam | Director |
| Paul A. Mieyal, Ph.D, Cfa | Director |
| Alexander Mironov | Executive |
| Edmundo Muniz, M.D., Ph.D. | Director, Executive |
| Georg Nebgen, Ph.D. | Director |
| Binh Nguyen, M.D., Ph.D. | Executive |
| Mark Pruzanski, M.D. | Director |
| Anne White | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3359 Woods Edge Circle Suite 103
Bonita Springs, FL, 34134
Bonita Springs, FL, 34134